HomeAbout Expertise Join Our TeamContact Acclaimed Content Part of the Springer Nature group, we provide access to a prestigious publishing portfolio and countless clinical society partners We are a global leader in healthcare education and communications Drawing on the vast experience and expertise of our worldwide network, Springer Healthcare delivers strategic medical communications solutions, high-level clinical and scientific content, specialized training programs, and targeted medical education initiatives across the full range of therapeutic areas. 0 1 8 9 offices worldwide 3 4 9 0 5 0 + employees worldwide 0 1 9 0 7 0 + specialized medical writers Education Targeted, cross-channel medical learning programs and news services Independent Medical Education Unrivaled content with innovative program design Medical News medwireNews bureau reports on the latest medical advances and opinion Training Specialized solutions for pharmaceutical, biotech, and medical devices > Strategic Communications Unparalleled communications programs to global pharmaceutical headquarters Communications Global and tactical campaigns, including localized support Content Provision Trusted, up-to-the-minute content for healthcare professionals Society Content Global sales and licensing for renowned publishers and societies Publishing The Adis portfolio of publications and solutions spanning all therapeutic areas Springer Healthcare Spotlight NEW: Official ESMO 2021 Highlights Programmes and ESMO 2021 Presentation Licensing ESMO with Springer Healthcare are offering a range of new programmes and content licensing opportunities to support additional dissemination and discussion of the latest data post-congress. Take advantage of this first-of-its-kind opportunity to support a live local event or create a customized collection of presentations ready for distribution post-congress, exclusively offered by Springer Healthcare. For the first time, ESMO with Springer Healthcare are brand new official highlights programmes to support the additional dissemination and discussion of the latest data post-congress. Choose from Best of ESMO or ESMO In Focus – both based on ESMO-selected core presentations from the ESMO Congress 2021 to provide opportunity for in-depth discussion and analysis of the latest scientific findings in primary disease sites and practice changing advances in cancer treatment, all in a local context, led by local experts. New and exclusive for 2021: license official ESMO Congress 2021 presentations for an extended audience via Springer Healthcare’s user friendly online formats. Include your abstract with associated media, and consider optional customisations, such as expert commentaries for additional context, and local language subtitles. Choose from a single presentation format or a collection format and deliver your ESMO content direct to your HCPs. Contact us to discuss your ESMO needs. Keep your publications on track with rapid publication and winning digital features from Adis Explore the new interactive racetrack infographic to find out about rapid and reliable publishing options from Adis, including: - Adis Drug Reviews - Presubmission enquiry service - Plain-language summaries - Open access options - Variety of journal options and article types - Digital features, including videos, infographics, animations and podcasts. - And much more…read more here. Springer Healthcare signs new global distributor agreement with ISTH Springer Healthcare is pleased to have signed a new global distributor agreement with the International Society on Thrombosis and Haemostasis to represent them for the promotion and sale of ISTH 2021 content. ISTH 2021 will be an entirely virtual experience taking place July 17-21, 2021. Contact us for further information. Celebrating 50 years of Drugs journal in 2021 The definitive journal of drugs and therapeutics reaches its 50th anniversary in 2021. We would like to thank all the contributors to the journal over the years. This milestone would not be possible without their incredible research, drive and commitment. Drugs is a peer-reviewed medical journal that covers topics in drugs and therapeutics. As well as research articles, the journal also publishes "Adis Drug Evaluations and AdisInsight Reports" - evidence-based, single-agent reviews. To find out more about our publishing services click here. Previous Next Discover the difference that only a proven leader can make. DISCOVER A global leader in medical education, communications, and training. © 2021 Springer Healthcare Limited. Part of Springer Nature Group. Privacy & Cookies Acclaimed Content Global Reach Diverse Delivery Join Our Team Contact Expertise Education Independent Medical Education Medical News Training Strategic Communications Communications Content Provision Society Content Publishing Our Brands Adis Journals inScience Communications MedEngine Medicine Matters medwireNews reprintsWarehouse.com Springer Healthcare IME Springer Healthcare Training Discover More… By submitting, you agree to our privacy policies Your Privacy We use cookies to make sure that our website works properly, as well as some ‘optional’ cookies to personalise content and advertising, provide social media features and analyse how people use our site. By accepting some or all optional cookies you give consent to the processing of your personal data, including transfer to third parties, some in countries outside of the European Economic Area that do not offer the same data protection standards as the country where you live. You can decide which optional cookies to accept by clicking on ‘Manage Settings’, where you can also find more information about how your personal data is processed. Further information can be found in our privacy policy. Accept All Cookies Manage Preferences